Global Health Policy

selected resources

Global Health Aid Cuts

This collection of resources chronicles what recent Trump administration global health aid cuts mean for the future of global health programs and the people who rely on them.

A promotional image for the the KFF Health Policy 101 U.S. Government and Global Health

The U.S. Government and Global Health

In this Health Policy 101 chapter, investigate the U.S. role in global health, including the major initiatives the United States supports, funding levels, and agencies involved in implementing program area efforts.

the essentials

Global Health Trackers

U.S. Global Health Budget Tracker

This tracker provides regularly updated information on U.S. government funding for global health. It includes historical trends and tracks funding levels for U.S. global health efforts through bilateral and multilateral contributions and by program area and agency.

Subscribe to KFF Emails

Choose which emails are best for you.
Sign up here

Filter

181 - 190 of 648 Results

  • Historical Trends in U.S. Funding for Global Health

    Issue Brief

    To provide context for the release of the administration’s first, full budget request for FY 2022, this brief provides an overview of historical trends in U.S. global health funding, including changes in program-specific funding over time, the distribution between bilateral and multilateral support, and in the increasing use of emergency supplemental funding in response to outbreaks.

  • Ahead of Biden’s Budget Proposal, A New KFF Analysis Takes a Closer Look at Historical Trends in the Global Health Budget

    News Release

    On May 28th, President Biden will release his first detailed budget proposal, covering the fiscal year starting in October 2021. As the largest global health donor in the world, the new budget proposal will provide a glimpse into what the Biden administration will be prioritizing for global health. In preparation for the budget release, KFF released a new brief looking at the historical trends in US funding for global health. Since FY 2001, US global…

  • Putting U.S. Global COVID-19 Vaccine Donations in Context

    Policy Watch

    While some have praised the most recent U.S. donation announcement as an important development, others have said the U.S. could do much more, pointing to the large supply of doses the U.S. is building up and the slowing demand for vaccinations in the country.  In this policy watch, we sought to put the U.S. pledge of 80 million doses in further context.

  • What Could the U.S. Do to Help Improve Global COVID-19 Vaccine Equity?

    News Release

    As India and other countries continue to grapple with major COVID-19 outbreaks even as cases decline in this country, there is increasing attention to the global role that could be played by the U.S. government.  This is particularly the case now that the U.S. will soon have enough COVID-19 vaccine doses to fully vaccinate everyone in the country, and has also purchased additional doses of vaccines not yet authorized in the U.S.  A new issue…

  • Global COVID-19 Vaccine Equity: U.S. Policy Options and Actions to Date

    Issue Brief

    This brief examines U.S. policy options for helping expand global access to COVID-19 vaccines, focusing on four main areas: in-kind donations of vaccine doses, additional funding for global access mechanisms like COVAX, helping expand global vaccine manufacturing, and relaxing or waiving intellectual property protections on vaccine technologies. We summarize what the administration has done to date in these areas and policy issues related to each.

  • Global COVID-19 Vaccine Access: A Snapshot of Inequality

    Policy Watch

    This policy watch examines global access to COVID-19 vaccines by country income level, assessing country income levels' shares of purchased doses and potential vaccination coverage, while also looking closely at the potential impact of COVAX in addressing vaccine access disparity between high-income and low- and middle-income countries.

  • Many Nonelderly People With Disabilities Face COVID-19 Risks Similar to Those of the Elderly in Nursing Homes, But Do Not Have Equal Footing When it Comes to Vaccine Priority

    News Release

    While the toll of COVID-19 on nursing home residents has been well documented, less noticed has been the experience of nonelderly people with disabilities who rely on long-term care services and supports outside of nursing homes. In many ways the two groups face similar health risks from the virus, but nonelderly people with disabilities generally do not have the same high priority status for the vaccine, finds a new KFF analysis. As of early February…

  • COVAX and the United States

    Issue Brief

    This issue brief provides an overview of COVAX, the global mechanism to secure and deliver COVID-19 vaccines. The brief details COVAX's organization, conditions for country participation, activities, and financing structure. Additionally, it looks at the history and remaining key issues of U.S. engagement with COVAX.

  • New KFF Analysis Finds 40 Out of 46 PEPFAR Countries Have Met At Least One HIV Target, Though No Countries Have Met All Progress Measures

    News Release

    A new KFF analysis finds that across 46 PEPFAR countries and among six different indicators of progress, the majority (40) has met at least one target, 17 countries have met at least half of the targets, and one country has met five targets. No country has met all targets and six have not met any target. The analysis is part of a dashboard that provides a detailed look at progress being made to address the…